CDKN2B and benign prostatic hyperplasia: Additionally, we observed significantly reduced mRNA expression levels of CCND1, p15INK4b, and RB in prostate tumor tissues compared to BPH tissues, while the expression levels of CDK4, CDK6, and p16INK4a remained unaltered.